Foley Partner Judith Waltz authored an article that appeared in the August 2010 edition of Medical Device and Diagnostic Industry titled “U.S. Focuses Enforcement on Manufacturers.” Waltz discusses increasing healthcare enforcement activity under the Obama administration, stating that the federal government has focused enforcement activity on how providers are billing products to government healthcare programs. She recommends that manufacturers review recent False Claims Act settlements and consider whether further scrutiny of their product support services and pricing strategies may be warranted.
Click here to read the complete article.
Author(s)
Related Insights
December 19, 2025
Health Care Law Today
Gender Affirming Care for Minors: CMS and HHS Propose Limits on “Sex Rejection Procedures” and Expanded Enforcement Pathways
On December 18, 2025, the U.S. Department of Health and Human Services (HHS) held a press conference focused on what is defined as “sex…
December 19, 2025
Foley Viewpoints
Prohibition to Prescription: What Trump’s Marijuana Executive Order Really Means
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that…
December 18, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…